Do exhaled non-invasive inflammatory markers correlate with respiratory symptoms and lung function in a longitudinal study of childhood asthma? Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011
Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006
Clinical relevance of small airways assessment by lung function tests in asthma Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018
Evaluation of asthma control test and correlation with objective measures of lung function and inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 367s Year: 2007
The use of FENO in COPD: the relationship to pulmonary function tests and its importance in differential diagnosis. Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017
Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020
Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012
Clinical characteristics, lung function, quality of life, exercise capacity and inflammatory biomarkers in induced sputum and serum in children and adolescents with uncontrolled severe asthma. Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
COPD: problems in diagnosis and measurement Source: Eur Respir J 2003; 21: 4S-12S Year: 2003
The relationship of exacerbations and lung function decline to radiologic characteristics in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005
The role of lung function testing and eNO in monitoring asthma Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice" Year: 2013
Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003
COPD assessment test correlation with the increase of the inflammatory markers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011